<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01082874</url>
  </required_header>
  <id_info>
    <org_study_id>POISE-2 01MAR2010</org_study_id>
    <secondary_id>2009-018173-31</secondary_id>
    <nct_id>NCT01082874</nct_id>
  </id_info>
  <brief_title>PeriOperative ISchemic Evaluation-2 Trial</brief_title>
  <acronym>POISE-2</acronym>
  <official_title>A Large, International, Placebo-controlled, Factorial Trial to Assess the Impact of Clonidine and Acetyl-salicylic Acid (ASA) in Patients Undergoing Noncardiac Surgery Who Are at Risk of a Perioperative Cardiovascular Event</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hamilton Health Sciences Corporation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Major surgeries not involving the heart are common, and major heart problems during or after
      such surgeries represent a large population health problem. Few treatments to prevent heart
      problems around the time of surgery have been tested. There is encouraging data suggesting
      that small doses of Acetyl-Salicylic Acid (ASA) and Clonidine, which are two medications,
      given individually for a short period before and after major surgeries may prevent major
      heart problems. The POISE-2 Trial is a large international study to test if ASA and Clonidine
      can prevent heart attacks and deaths from heart problems around the time of surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      POISE-2 is a multicentre, international, blinded, 2x2 factorial randomized controlled trial
      of acetyl-salicylic acid (ASA) and clonidine. The primary objective is to determine the
      impact of clonidine versus placebo and ASA versus placebo on the 30-day risk of all-cause
      mortality or nonfatal myocardial infarction in patients with, or at risk of, atherosclerotic
      disease who are undergoing noncardiac surgery. Patients in the POISE-2 trial will be randomly
      assigned to one of four groups: ASA and Clonidine together, ASA and Clonidine placebo, ASA
      placebo and Clonidine, or a ASA placebo and Clonidine placebo. Research personnel will follow
      patients at 30 days post-randomization and 1 year post-randomization.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of All-cause Mortality and Nonfatal MI</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>All-cause Mortality and Nonfatal MI</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite of All-cause Mortality, Nonfatal MI, and Nonfatal Stroke</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Individual Secondary Outcomes</measure>
    <time_frame>30 days</time_frame>
    <description>All-cause mortality, vascular mortality, MI, nonfatal cardiac arrest, cardiac revascularization procedure, pulmonary emboli, deep venous thrombosis, clinically important atrial fibrillation, amputation, peripheral arterial thrombosis, infection/sepsis, rehospitalization for vascular reasons, length of hospital stay, length of intensive care unit / cardiac care unit (ICU/CCU) stay, and new acute renal failure requiring dialysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite Outcome by ASA Stratum</measure>
    <time_frame>30 days</time_frame>
    <description>Composite outcome of all-cause mortality, nonfatal MI, cardiac revascularization procedure, nonfatal pulmonary emboli, and nonfatal deep venous thrombosis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety Outcomes in ASA Trial</measure>
    <time_frame>30 days</time_frame>
    <description>Stroke, congestive heart failure, life-threatening bleeding, and major bleeding.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety Outcomes in Clonidine Trial</measure>
    <time_frame>30 days</time_frame>
    <description>Stroke, clinically important hypotension, clinically important bradycardia, and congestive heart failure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite Outcome at 1 Year</measure>
    <time_frame>1 year</time_frame>
    <description>All-cause mortality, nonfatal MI, and nonfatal stroke.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Individual Secondary Outcomes at 1 Year</measure>
    <time_frame>1 year</time_frame>
    <description>All cause mortality, vascular mortality, MI, nonfatal cardiac arrest, cardiac revascularization procedure, stroke, pulmonary emboli, deep venous thrombosis, amputation, peripheral arterial thrombosis, new diagnosis of cancer, diagnosis of recurrent cancer and rehospitalization for vascular reason.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">10010</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Active Clonidine and Active ASA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Clonidine and Placebo ASA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Clonidine and Active ASA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Clonidine and Placebo ASA</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Active Clonidine</intervention_name>
    <description>Pre-op (goal 2-4 hours): 2 x 0.1mg oral tablets and transdermal patch (0.2 mg/day). Patch to be removed 72 hours post-op.</description>
    <arm_group_label>Active Clonidine and Active ASA</arm_group_label>
    <arm_group_label>Active Clonidine and Placebo ASA</arm_group_label>
    <other_name>CATAPRES, CATAPRES-TTS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Clonidine</intervention_name>
    <description>Pre-op (goal 2-4 hours): 2 oral placebo tablets and transdermal placebo patch. Patch to be removed 72 hours post-op.</description>
    <arm_group_label>Placebo Clonidine and Active ASA</arm_group_label>
    <arm_group_label>Placebo Clonidine and Placebo ASA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Active ASA</intervention_name>
    <description>Pre-op (goal 2-4 hours): 2 x 100mg oral tablets. Post-op: patients ingest one tablet a day (100 mg ASA) for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
    <arm_group_label>Active Clonidine and Active ASA</arm_group_label>
    <arm_group_label>Placebo Clonidine and Active ASA</arm_group_label>
    <other_name>ASPIRIN</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo ASA</intervention_name>
    <description>Pre-op (goal 2-4 hours): 2 oral placebo tablets. Post-op: patients ingest one placebo tablet a day for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
    <arm_group_label>Active Clonidine and Placebo ASA</arm_group_label>
    <arm_group_label>Placebo Clonidine and Placebo ASA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Are undergoing noncardiac surgery;

          2. Are â‰¥ 45 years of age;

          3. Are expected to require at least an overnight hospital admission after surgery; AND

          4. Fulfill one or more of the following 5 criteria:

               -  History of coronary artery disease

               -  History of peripheral vascular disease

               -  History of stroke

               -  Undergoing major vascular surgery

               -  Any 3 of the following 9 criteria:

                    -  undergoing major surgery (i.e. intraperitoneal, intrathoracic,
                       retroperitoneal or major orthopedic surgery

                    -  history of congestive heart failure

                    -  transient ischemic attack

                    -  diabetes and currently taking an oral hypoglycemic agent or insulin

                    -  age â‰¥ 70 years

                    -  hypertension

                    -  serum creatinine &gt; 175 Âµmol/L (&gt; 2.0 mg/dL)

                    -  history of smoking within 2 years of surgery

                    -  undergoing urgent/emergent surgery

        Exclusion Criteria:

          1. Consumption of ASA within 72 hours prior to surgery

          2. Hypersensitivity or known allergy to ASA or clonidine

          3. Systolic blood pressure &lt; 105 mm Hg

          4. Heart rate &lt; 55 beats per minute in a patient who does not have a permanent pacemaker

          5. Second or third degree heart block without a permanent pacemaker

          6. Active peptic ulcer disease or gastrointestinal bleeding within previous 6 weeks

          7. Intracranial hemorrhage documented by neuro-imaging, in the 6 months prior to
             randomization. This does not include petechial hemorrhagic transformation of a primary
             ischemic stroke

          8. Subarachnoid hemorrhage or epidural hematoma unless the event occurred more than 6
             months prior to randomization and the offending aneurysm or arterial lesion has been
             repaired

          9. Drug-eluting coronary stent in the year prior to randomization

         10. Bare-metal coronary stent in the 6 weeks prior to randomization

         11. Thienopyridine (e.g., clopidogrel, ticlopidine, prasugrel) or ticagrelor within 72
             hours prior to surgery; or intent to restart a thienopyridine or ticagrelor during the
             first 7 days post-op; or currently taking an alpha-2 agonist, alpha methyldopa,
             monoamine oxidase inhibitors or reserpine;

         12. Planned use - during the first 3 days after surgery - therapeutic dose anticoagulation
             or a therapeutic subcutaneous or intravenous antithrombotic agent

         13. Undergoing intracranial surgery, carotid endarterectomy, or retinal surgery

         14. Not consenting to participate in POISE-2 prior to surgery

         15. Previously enrolled in POISE-2 Trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>P.J. Devereaux, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Population Health Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Salim Yusuf, DPhil</last_name>
    <role>Study Chair</role>
    <affiliation>Population Health Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Rosario</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office Australia and New Zealand</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Bucamaranga</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Herlev</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Boulogne-Billancourt</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Bangalore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Islamabad</city>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Durban</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Coordination Office</name>
      <address>
        <city>Hull</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Colombia</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hong Kong</country>
    <country>India</country>
    <country>Italy</country>
    <country>Malaysia</country>
    <country>New Zealand</country>
    <country>Pakistan</country>
    <country>Peru</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>China</country>
    <country>Egypt</country>
    <country>El Salvador</country>
    <country>Hungary</country>
  </removed_countries>
  <results_reference>
    <citation>Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A, Villar JC, Sigamani A, Biccard BM, Meyhoff CS, Parlow JL, Guyatt G, Robinson A, Garg AX, Rodseth RN, Botto F, Lurati Buse G, Xavier D, Chan MT, Tiboni M, Cook D, Kumar PA, Forget P, Malaga G, Fleischmann E, Amir M, Eikelboom J, Mizera R, Torres D, Wang CY, VanHelder T, Paniagua P, Berwanger O, Srinathan S, Graham M, Pasin L, Le Manach Y, Gao P, Pogue J, Whitlock R, Lamy A, Kearon C, Baigent C, Chow C, Pettit S, Chrolavicius S, Yusuf S; POISE-2 Investigators. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014 Apr 17;370(16):1494-503. doi: 10.1056/NEJMoa1401105. Epub 2014 Mar 31.</citation>
    <PMID>24679062</PMID>
  </results_reference>
  <results_reference>
    <citation>Devereaux PJ, Sessler DI, Leslie K, Kurz A, Mrkobrada M, Alonso-Coello P, Villar JC, Sigamani A, Biccard BM, Meyhoff CS, Parlow JL, Guyatt G, Robinson A, Garg AX, Rodseth RN, Botto F, Lurati Buse G, Xavier D, Chan MT, Tiboni M, Cook D, Kumar PA, Forget P, Malaga G, Fleischmann E, Amir M, Eikelboom J, Mizera R, Torres D, Wang CY, Vanhelder T, Paniagua P, Berwanger O, Srinathan S, Graham M, Pasin L, Le Manach Y, Gao P, Pogue J, Whitlock R, Lamy A, Kearon C, Chow C, Pettit S, Chrolavicius S, Yusuf S; POISE-2 Investigators. Clonidine in patients undergoing noncardiac surgery. N Engl J Med. 2014 Apr 17;370(16):1504-13. doi: 10.1056/NEJMoa1401106. Epub 2014 Mar 31.</citation>
    <PMID>24679061</PMID>
  </results_reference>
  <results_reference>
    <citation>Garg AX, Kurz A, Sessler DI, Cuerden M, Robinson A, Mrkobrada M, Parikh C, Mizera R, Jones PM, Tiboni M, Rodriguez RG, Popova E, Rojas Gomez MF, Meyhoff CS, Vanhelder T, Chan MT, Torres D, Parlow J, de Nadal Clanchet M, Amir M, Bidgoli SJ, Pasin L, Martinsen K, Malaga G, Myles P, Acedillo R, Roshanov P, Walsh M, Dresser G, Kumar P, Fleischmann E, Villar JC, Painter T, Biccard B, Bergese S, Srinathan S, Cata JP, Chan V, Mehra B, Leslie K, Whitlock R, Devereaux PJ; POISE-2 Investigators. Aspirin and clonidine in non-cardiac surgery: acute kidney injury substudy protocol of the Perioperative Ischaemic Evaluation (POISE) 2 randomised controlled trial. BMJ Open. 2014 Feb 25;4(2):e004886. doi: 10.1136/bmjopen-2014-004886.</citation>
    <PMID>24568963</PMID>
  </results_reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2010</study_first_submitted>
  <study_first_submitted_qc>March 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2010</study_first_posted>
  <results_first_submitted>July 14, 2016</results_first_submitted>
  <results_first_submitted_qc>July 14, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 25, 2016</results_first_posted>
  <last_update_submitted>July 14, 2016</last_update_submitted>
  <last_update_submitted_qc>July 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Randomized Controlled Trial</keyword>
  <keyword>Blinded</keyword>
  <keyword>Clonidine</keyword>
  <keyword>acetyl-salicylic acid (ASA)</keyword>
  <keyword>Perioperative vascular complications</keyword>
  <keyword>Noncardiac surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clonidine</mesh_term>
    <mesh_term>Salicylates</mesh_term>
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Salicylic Acid</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Active Clonidine and Active ASA</title>
          <description>Active Clonidine: Pre-op (goal 2-4 hours): 2 x 0.1mg oral tablets and transdermal patch (0.2 mg/day). Patch to be removed 72 hours post-op.
Active ASA: Pre-op (goal 2-4 hours): 2 x 100mg oral tablets. Post-op: patients ingest one tablet a day (100 mg ASA) for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
        </group>
        <group group_id="P2">
          <title>Active Clonidine and Placebo ASA</title>
          <description>Active Clonidine: Pre-op (goal 2-4 hours): 2 x 0.1mg oral tablets and transdermal patch (0.2 mg/day). Patch to be removed 72 hours post-op.
Placebo ASA: Pre-op (goal 2-4 hours): 2 oral placebo tablets. Post-op: patients ingest one placebo tablet a day for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
        </group>
        <group group_id="P3">
          <title>Placebo Clonidine and Active ASA</title>
          <description>Placebo Clonidine: Pre-op (goal 2-4 hours): 2 oral placebo tablets and transdermal placebo patch. Patch to be removed 72 hours post-op.
Active ASA: Pre-op (goal 2-4 hours): 2 x 100mg oral tablets. Post-op: patients ingest one tablet a day (100 mg ASA) for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
        </group>
        <group group_id="P4">
          <title>Placebo Clonidine and Placebo ASA</title>
          <description>Placebo Clonidine: Pre-op (goal 2-4 hours): 2 oral placebo tablets and transdermal placebo patch. Patch to be removed 72 hours post-op.
Placebo ASA: Pre-op (goal 2-4 hours): 2 oral placebo tablets. Post-op: patients ingest one placebo tablet a day for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2499"/>
                <participants group_id="P2" count="2510"/>
                <participants group_id="P3" count="2499"/>
                <participants group_id="P4" count="2502"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2488"/>
                <participants group_id="P2" count="2498"/>
                <participants group_id="P3" count="2488"/>
                <participants group_id="P4" count="2489"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="12"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Active Clonidine and Active ASA</title>
          <description>Active Clonidine: Pre-op (goal 2-4 hours): 2 x 0.1mg oral tablets and transdermal patch (0.2 mg/day). Patch to be removed 72 hours post-op.
Active ASA: Pre-op (goal 2-4 hours): 2 x 100mg oral tablets. Post-op: patients ingest one tablet a day (100 mg ASA) for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
        </group>
        <group group_id="B2">
          <title>Active Clonidine and Placebo ASA</title>
          <description>Active Clonidine: Pre-op (goal 2-4 hours): 2 x 0.1mg oral tablets and transdermal patch (0.2 mg/day). Patch to be removed 72 hours post-op.
Placebo ASA: Pre-op (goal 2-4 hours): 2 oral placebo tablets. Post-op: patients ingest one placebo tablet a day for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
        </group>
        <group group_id="B3">
          <title>Placebo Clonidine and Active ASA</title>
          <description>Placebo Clonidine: Pre-op (goal 2-4 hours): 2 oral placebo tablets and transdermal placebo patch. Patch to be removed 72 hours post-op.
Active ASA: Pre-op (goal 2-4 hours): 2 x 100mg oral tablets. Post-op: patients ingest one tablet a day (100 mg ASA) for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
        </group>
        <group group_id="B4">
          <title>Placebo Clonidine and Placebo ASA</title>
          <description>Placebo Clonidine: Pre-op (goal 2-4 hours): 2 oral placebo tablets and transdermal placebo patch. Patch to be removed 72 hours post-op.
Placebo ASA: Pre-op (goal 2-4 hours): 2 oral placebo tablets. Post-op: patients ingest one placebo tablet a day for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2499"/>
            <count group_id="B2" value="2510"/>
            <count group_id="B3" value="2499"/>
            <count group_id="B4" value="2502"/>
            <count group_id="B5" value="10010"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="873"/>
                    <measurement group_id="B2" value="836"/>
                    <measurement group_id="B3" value="836"/>
                    <measurement group_id="B4" value="866"/>
                    <measurement group_id="B5" value="3411"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1626"/>
                    <measurement group_id="B2" value="1674"/>
                    <measurement group_id="B3" value="1663"/>
                    <measurement group_id="B4" value="1636"/>
                    <measurement group_id="B5" value="6599"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.4" spread="10.4"/>
                    <measurement group_id="B2" value="68.6" spread="10.3"/>
                    <measurement group_id="B3" value="68.7" spread="10.2"/>
                    <measurement group_id="B4" value="68.5" spread="10.3"/>
                    <measurement group_id="B5" value="68.6" spread="10.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1212"/>
                    <measurement group_id="B2" value="1164"/>
                    <measurement group_id="B3" value="1188"/>
                    <measurement group_id="B4" value="1160"/>
                    <measurement group_id="B5" value="4724"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1287"/>
                    <measurement group_id="B2" value="1346"/>
                    <measurement group_id="B3" value="1310"/>
                    <measurement group_id="B4" value="1340"/>
                    <measurement group_id="B5" value="5283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Colombia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="161"/>
                    <measurement group_id="B3" value="164"/>
                    <measurement group_id="B4" value="162"/>
                    <measurement group_id="B5" value="649"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Argentina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hong Kong</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="70"/>
                    <measurement group_id="B3" value="69"/>
                    <measurement group_id="B4" value="68"/>
                    <measurement group_id="B5" value="276"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="443"/>
                    <measurement group_id="B2" value="440"/>
                    <measurement group_id="B3" value="437"/>
                    <measurement group_id="B4" value="440"/>
                    <measurement group_id="B5" value="1760"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Malaysia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="32"/>
                    <measurement group_id="B5" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="23"/>
                    <measurement group_id="B5" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>India</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="149"/>
                    <measurement group_id="B2" value="149"/>
                    <measurement group_id="B3" value="151"/>
                    <measurement group_id="B4" value="146"/>
                    <measurement group_id="B5" value="595"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="133"/>
                    <measurement group_id="B2" value="139"/>
                    <measurement group_id="B3" value="131"/>
                    <measurement group_id="B4" value="135"/>
                    <measurement group_id="B5" value="538"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New Zealand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="875"/>
                    <measurement group_id="B2" value="878"/>
                    <measurement group_id="B3" value="872"/>
                    <measurement group_id="B4" value="873"/>
                    <measurement group_id="B5" value="3498"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Austria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="42"/>
                    <measurement group_id="B4" value="46"/>
                    <measurement group_id="B5" value="176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pakistan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="44"/>
                    <measurement group_id="B4" value="44"/>
                    <measurement group_id="B5" value="175"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Belgium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="46"/>
                    <measurement group_id="B4" value="47"/>
                    <measurement group_id="B5" value="184"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Brazil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="16"/>
                    <measurement group_id="B5" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Denmark</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                    <measurement group_id="B2" value="80"/>
                    <measurement group_id="B3" value="80"/>
                    <measurement group_id="B4" value="81"/>
                    <measurement group_id="B5" value="321"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="38"/>
                    <measurement group_id="B4" value="38"/>
                    <measurement group_id="B5" value="154"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>South Africa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                    <measurement group_id="B2" value="87"/>
                    <measurement group_id="B3" value="89"/>
                    <measurement group_id="B4" value="90"/>
                    <measurement group_id="B5" value="353"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Australia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="119"/>
                    <measurement group_id="B2" value="120"/>
                    <measurement group_id="B3" value="113"/>
                    <measurement group_id="B4" value="118"/>
                    <measurement group_id="B5" value="470"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chile</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="38"/>
                    <measurement group_id="B4" value="39"/>
                    <measurement group_id="B5" value="153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peru</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="44"/>
                    <measurement group_id="B5" value="172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Composite of All-cause Mortality and Nonfatal MI</title>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active Clonidine and Active ASA</title>
            <description>Active Clonidine: Pre-op (goal 2-4 hours): 2 x 0.1mg oral tablets and transdermal patch (0.2 mg/day). Patch to be removed 72 hours post-op.
Active ASA: Pre-op (goal 2-4 hours): 2 x 100mg oral tablets. Post-op: patients ingest one tablet a day (100 mg ASA) for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
          </group>
          <group group_id="O2">
            <title>Active Clonidine and Placebo ASA</title>
            <description>Active Clonidine: Pre-op (goal 2-4 hours): 2 x 0.1mg oral tablets and transdermal patch (0.2 mg/day). Patch to be removed 72 hours post-op.
Placebo ASA: Pre-op (goal 2-4 hours): 2 oral placebo tablets. Post-op: patients ingest one placebo tablet a day for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
          </group>
          <group group_id="O3">
            <title>Placebo Clonidine and Active ASA</title>
            <description>Placebo Clonidine: Pre-op (goal 2-4 hours): 2 oral placebo tablets and transdermal placebo patch. Patch to be removed 72 hours post-op.
Active ASA: Pre-op (goal 2-4 hours): 2 x 100mg oral tablets. Post-op: patients ingest one tablet a day (100 mg ASA) for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
          </group>
          <group group_id="O4">
            <title>Placebo Clonidine and Placebo ASA</title>
            <description>Placebo Clonidine: Pre-op (goal 2-4 hours): 2 oral placebo tablets and transdermal placebo patch. Patch to be removed 72 hours post-op.
Placebo ASA: Pre-op (goal 2-4 hours): 2 oral placebo tablets. Post-op: patients ingest one placebo tablet a day for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Composite of All-cause Mortality and Nonfatal MI</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2499"/>
                <count group_id="O2" value="2510"/>
                <count group_id="O3" value="2499"/>
                <count group_id="O4" value="2502"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="173"/>
                    <measurement group_id="O2" value="194"/>
                    <measurement group_id="O3" value="178"/>
                    <measurement group_id="O4" value="161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>All-cause Mortality and Nonfatal MI</title>
        <time_frame>1 year</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite of All-cause Mortality, Nonfatal MI, and Nonfatal Stroke</title>
        <time_frame>30 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Individual Secondary Outcomes</title>
        <description>All-cause mortality, vascular mortality, MI, nonfatal cardiac arrest, cardiac revascularization procedure, pulmonary emboli, deep venous thrombosis, clinically important atrial fibrillation, amputation, peripheral arterial thrombosis, infection/sepsis, rehospitalization for vascular reasons, length of hospital stay, length of intensive care unit / cardiac care unit (ICU/CCU) stay, and new acute renal failure requiring dialysis.</description>
        <time_frame>30 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite Outcome by ASA Stratum</title>
        <description>Composite outcome of all-cause mortality, nonfatal MI, cardiac revascularization procedure, nonfatal pulmonary emboli, and nonfatal deep venous thrombosis.</description>
        <time_frame>30 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Safety Outcomes in ASA Trial</title>
        <description>Stroke, congestive heart failure, life-threatening bleeding, and major bleeding.</description>
        <time_frame>30 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Safety Outcomes in Clonidine Trial</title>
        <description>Stroke, clinically important hypotension, clinically important bradycardia, and congestive heart failure.</description>
        <time_frame>30 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite Outcome at 1 Year</title>
        <description>All-cause mortality, nonfatal MI, and nonfatal stroke.</description>
        <time_frame>1 year</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Individual Secondary Outcomes at 1 Year</title>
        <description>All cause mortality, vascular mortality, MI, nonfatal cardiac arrest, cardiac revascularization procedure, stroke, pulmonary emboli, deep venous thrombosis, amputation, peripheral arterial thrombosis, new diagnosis of cancer, diagnosis of recurrent cancer and rehospitalization for vascular reason.</description>
        <time_frame>1 year</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Active Clonidine and Active ASA</title>
          <description>Active Clonidine: Pre-op (goal 2-4 hours): 2 x 0.1mg oral tablets and transdermal patch (0.2 mg/day). Patch to be removed 72 hours post-op.
Active ASA: Pre-op (goal 2-4 hours): 2 x 100mg oral tablets. Post-op: patients ingest one tablet a day (100 mg ASA) for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
        </group>
        <group group_id="E2">
          <title>Active Clonidine and Placebo ASA</title>
          <description>Active Clonidine: Pre-op (goal 2-4 hours): 2 x 0.1mg oral tablets and transdermal patch (0.2 mg/day). Patch to be removed 72 hours post-op.
Placebo ASA: Pre-op (goal 2-4 hours): 2 oral placebo tablets. Post-op: patients ingest one placebo tablet a day for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
        </group>
        <group group_id="E3">
          <title>Placebo Clonidine and Active ASA</title>
          <description>Placebo Clonidine: Pre-op (goal 2-4 hours): 2 oral placebo tablets and transdermal placebo patch. Patch to be removed 72 hours post-op.
Active ASA: Pre-op (goal 2-4 hours): 2 x 100mg oral tablets. Post-op: patients ingest one tablet a day (100 mg ASA) for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
        </group>
        <group group_id="E4">
          <title>Placebo Clonidine and Placebo ASA</title>
          <description>Placebo Clonidine: Pre-op (goal 2-4 hours): 2 oral placebo tablets and transdermal placebo patch. Patch to be removed 72 hours post-op.
Placebo ASA: Pre-op (goal 2-4 hours): 2 oral placebo tablets. Post-op: patients ingest one placebo tablet a day for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="2499"/>
                <counts group_id="E2" subjects_affected="52" subjects_at_risk="2510"/>
                <counts group_id="E3" subjects_affected="45" subjects_at_risk="2499"/>
                <counts group_id="E4" subjects_affected="39" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Dissemianted intravascular coagulation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>atrial fibrillation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Atrial Flutter</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Sinus Arrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Supraventricular Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Tachy Arrythymia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Open Angle Glaucoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Distension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Enterocutaneous Fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Enterovesicle Fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>GI Hemmorhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Hernial Eventration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Intestinal Dilatation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Intestinal Fistuala</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Intestinal Ischemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Intestinal Obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Intestinal Perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Large Intestine Perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Mesenteric Vein Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Pneumoretroperitonium</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Rectum hemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Samll Intestinal Obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Device Dislocation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Impaired Healing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Multi-organ Failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis Acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Cirrhosis Alcoholic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Ischemic Hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Portal Vein Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug Hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Abdominal Wound Dehisence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Anastomotic Leak</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Ankle Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Bladder Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Endotrachial Intubation complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Fascial Rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Femur Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Anastomotic Leak</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Stoma Necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Humerous Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Incision Site Hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Incisional Hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Joint Dislocation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Lymphatic Duct Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Pancreatic leak</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Postoperative Ileus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Postoperative Thoracic Procedure Complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Subcutaneous Hematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Subdural Hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Wound Evisceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Wound Hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood Pressure Systolic Increase</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Hemoglobin decrease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Internatinal Normalized Ratio Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Liver Functin Test Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Thoracic Cavity Drainage test Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Electrolyte Imbalance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Hypercalcemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Hyperglycemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Hyponatremia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Muscular Weakness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>b-Cell Lymphoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Myeloproliferative disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Neuroendocrine Carcinoma Metatastic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Transitional Cell Carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cognitive Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Loss of Consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Peroneal Nerve Palsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Pre-syncope</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>TIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Vasculitis Cerebral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Vocal Cord Paralysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Confusinal State</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Dilirium</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Emotional Distress</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Mental Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Pre-renal Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Pelvic-UretericObstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Renal Cyst Rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Renal Failure Acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Renal Ischemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Actue Respiratory Distress syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Acute Respiratory Failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Broncho Spasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Chylothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>pleural Effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Pneumonia Aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Pulmonary Edema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Respiratory Arrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Respiratory Depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Respiratory Distress</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2510"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="2499"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Decubitus Ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Dermatitis Allergic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Subcutaneous Emphysema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Lymphocele</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>lymphorrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
              <event>
                <sub_title>Orthostatic Hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2499"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2499"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2502"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>P.J. Devereaux, MD, PhD, FRCPC</name_or_title>
      <organization>Population Health Research Institute</organization>
      <phone>905-527-4322 ext 40654</phone>
      <email>philipj@mcmaster.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

